Asian market
Seven Steps To Considering Clinical Trials in Asia
September 20 by Pharma IQLarge patient pools and lower costs are just two of the enticing advantages of conducting clinical trials in Asia. Yet for many in the industry, the inner workings of the Asian market – and in...
Biosimilar Capabilities and Market Potential in Asia
June 29 by Pharma IQEpogen, Neupogen and Enbrel are three biologics which have already seen their patents expire, and Herceptin and Avastin are to be added to this list in the not too distant future. By 2015 the global...